Category: Disclosures

[Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in the U.S. / 2024-08-12

August 12, 2024August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion announced that the U.S. Food and Drug Administration (FDA) has approved its global Phase 3 clinical trial plan for CT-P51 to evaluate efficacy and safety compared with Keytruda in patients with non-small cell lung cancer. 📊 [Key Disclosure Details & Financial Highlights] 📝 Editor’s Comment…

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Systems (272210) – Sales/Supply Contract / 2024-08-09

August 9, 2024August 11, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems has signed a contract worth approximately KRW 84.0B with the Defense Acquisition Program Administration for Performance-Based Logistics (PBL) for TOD-III Repair Parts and 6 other items. 📊 [Key Disclosure Details & Financial Metrics] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Contract Performance Progress and…

Disclosures, Defense

[Disclosure] Wonik IPS (240810) – Consolidated Financial Results (Provisional) / 2024-08-08

August 8, 2024August 3, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Wonik IPS reported Q2 2024 consolidated revenue of KRW 154.9B and an operating loss of KRW 3.1B, while its net profit reached KRW 7.0B, turning to a profit both QoQ and YoY. 📊 [Key Disclosure Contents & Summary Metrics] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌…

Semiconductors, Disclosures

[Disclosure] Celltrion (068270) – Additional Listing (Stock Option Exercise) / 2024-08-08

August 8, 2024August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion announced the additional listing of 27,967 new common shares on August 13, 2024, issued following the exercise of stock options. 📊 [Key Disclosure Details & Financial Highlights] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Total Issued Shares and Stock Quantity Changes Post-Listing This…

Disclosures, Bio & Healthcare

[Disclosure] KEPCO (015760 / KEP) – Preliminary Earnings Results (Consolidated) / 2024-08-08

August 8, 2024August 13, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART Market: KOSPI (015760) 💡 3-Second Summary KEPCO posted a Q2 2024 consolidated operating profit of KRW 1.250T, bringing its H1 cumulative operating profit to KRW 2.550T and turning profitable year-on-year. 📊 [Key Disclosure Contents & Major Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Final Confirmed…

Disclosures, Energy

[Disclosure] Celltrion (068270) – Provisional Sales Results / 2024-08-07

August 7, 2024August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion reported its provisional Q2 2024 separate financial results, recording revenue of approximately KRW 973.2B and operating profit of approximately KRW 313.1B, representing a 987.57% QoQ increase in operating profit. 📊 [Key Disclosure Details & Financial Highlights] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Comparison Between…

Disclosures, Bio & Healthcare

[Disclosure] Hana Micron (067310) – Ex-Rights (Bonus Issue) / 2024-08-07

August 7, 2024August 2, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 Executive Summary An ex-rights adjustment for Hana Micron common stock will be executed on August 8, 2024, due to a bonus issue, with the reference price set at KRW 15,160. 📊 Key Disclosure Content & Financial Figures Summary 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Ex-Rights…

Semiconductors, Disclosures

[Disclosure] HPSP (403870) – Decision on Conclusion of Trust Contract for Treasury Stock Acquisition / 2024-08-07

August 7, 2024August 2, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary HPSP decided to enter into a new KRW 50,000,000,000 trust contract with Samsung Securities to acquire treasury shares for stock price stabilization and shareholder value enhancement. 📊 [Key Disclosure Contents & Summary Metrics] 1. Trust Contract Overview 2. Treasury Stock Acquisition Limit & Related Metrics 3….

Semiconductors, Disclosures

[Disclosure] HPSP (403870) – (Correction) Decision on Conclusion of Trust Contract for Treasury Stock Acquisition / 2024-08-07

August 7, 2024August 2, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary HPSP entered into a new KRW 50,000,000,000 trust contract to acquire treasury shares for stock price stabilization and shareholder value enhancement, while correcting certain calculation metrics regarding its dividend capacity limit. 📊 [Key Disclosure Contents & Summary Metrics] 1. Trust Contract Overview 2. Details of Corrections…

Semiconductors, Disclosures

[Disclosure] Hanwha Aerospace (012450) – Investor Alert for Stock Futures and Options / 2024-08-07

August 7, 2024August 10, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary In light of Hanwha Aerospace’s corporate spin-off decision, Korea Exchange provided advance notice that the final trading day for its stock futures and options will be advanced to August 28, 2024, and new contract month listings will cease upon shareholder approval. 📊 [Key Disclosure Details &…

Disclosures, Defense